Duloxetine, Gabapentin, and the Risk for Acute Myocardial Infarction, Stroke, and Out-of-Hospital Death in Medicare Beneficiaries With Non-Cancer Pain.
Meghan A CorriereAlyson L DicksonLaura L DanielPuran NepalKathi HallW Dale PlummerWilliam D DupontKatherine T MurrayC Michael SteinWayne A RayCecilia P ChungPublished in: The Clinical journal of pain (2023)
In summary, cohort Medicare patients with non-cancer pain beginning treatment with duloxetine had rates of AMI, stroke, and out-of-hospital mortality comparable to those who initiated gabapentin.
Keyphrases
- acute myocardial infarction
- neuropathic pain
- papillary thyroid
- chronic pain
- atrial fibrillation
- healthcare
- squamous cell
- spinal cord
- percutaneous coronary intervention
- left ventricular
- spinal cord injury
- type diabetes
- lymph node metastasis
- heart failure
- childhood cancer
- cardiovascular events
- risk factors
- squamous cell carcinoma
- cardiovascular disease